Results 331 to 340 of about 3,613,662 (378)
Some of the next articles are maybe not open access.
Skin manifestations of Pseudomonas aeruginosa infections.
Current Opinion in Infectious Diseases, 2021PURPOSE OF REVIEW Pseudomonas aeruginosa is an opportunistic pathogen with considerable morbidity and mortality, particularly in vulnerable hosts. Skin manifestations are common, either representing local inoculation or secondary skin seeding following ...
Nikolaos Spernovasilis +2 more
semanticscholar +1 more source
Immunotherapy of Pseudomonas Infections
Annals of Internal Medicine, 1967Excerpt An increasingly serious problem for the past decade or more has been the rising prevalence of infections due toPseudomonas aeruginosa.
K. Markley, Jerome R. Klingbeil
openaire +5 more sources
Pseudomonas Infection of the Nose
Archives of Otolaryngology - Head and Neck Surgery, 1980We report an unusual complication of nasal surgery. A rare, localized Pseudomonas infection of the nose developed after a routine submucous resection and nasal reconstruction in a healthy 56-year-old woman. We emphasize the need for early aggressive management in the treatment of Pseudomonas infections of the nose.
William J. Binder, Frank M. Kamer
openaire +3 more sources
Pseudomonas AeruginosaInfections
CRC Critical Reviews in Clinical Laboratory Sciences, 1972(1972). Pseudomonas Aeruginosa Infections. CRC Critical Reviews in Clinical Laboratory Sciences: Vol. 3, No. 3, pp. 291-347.
D. Amstrong, L. S. Young
openaire +3 more sources
Archives of Otolaryngology - Head and Neck Surgery, 1996
I read the article by Dohar et al 1 with interest. Their finding concerning the efficacy of piperacillin and tobramycin against aural isolates of Pseudomonas aeruginosa is consistent with the sensitivity data at our institution in Honolulu, Hawaii (piperacillin, 97%; tobramycin, 100%).
openaire +3 more sources
I read the article by Dohar et al 1 with interest. Their finding concerning the efficacy of piperacillin and tobramycin against aural isolates of Pseudomonas aeruginosa is consistent with the sensitivity data at our institution in Honolulu, Hawaii (piperacillin, 97%; tobramycin, 100%).
openaire +3 more sources
The Therapeutic Pipeline for Pseudomonas aeruginosa Infections.
ACS Infectious Diseases, 2018Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen, designated by the World Health Organization as a critical priority for development of new therapeutics due to high levels of intrinsic and acquired antibiotic resistance.
L. Burrows
semanticscholar +1 more source
Rational approach in the management of Pseudomonas aeruginosa infections
Current Opinion in Infectious Diseases, 2018Purpose of review This review details the management of Pseudomonas aeruginosa infections covering both current and future treatment options that are and may be available for the clinicians.
M. Bassetti +5 more
semanticscholar +1 more source
Colonization and. Infection with Pseudomonas cepacia
Journal of Infectious Diseases, 1972The pseudomonad EO-1 (Eugonic Oxidizer Group 1) or Pseudomonas cepacia, multivorans, or kingii was isolated from 41 patients over a two-year period at the University of Minnesota Hospitals. All patients had significant underlying medical problems.
John M. Matsen, Grace Mary Ederer
openaire +3 more sources
Pseudomonas Aeruginosa in Oral Infections
Acta Odontologica Scandinavica, 1972Twentynine strains of Pseudomonas aeruginosa were isolated from 2518 specimens from patients with oral infections and the following clinical diagnoses: periodontitis apicalis, necrosis pulpae, pulpitis and alveolitis maxillaris and mandibularis.
L. Sjöberg +2 more
openaire +3 more sources